High-Deductible Health Plan Enrollment and Buprenorphine Dispensing - Takeaways - MDSpire

High-Deductible Health Plan Enrollment and Buprenorphine Dispensing

  • By

  • Kao-Ping Chua

  • Amy S. Bohnert

  • Rena M. Conti

  • Pooja Lagisetty

  • Ushapoorna Nuliyalu

  • Thuy D. Nguyen

  • May 28, 2026

  • 0 min

Share

  • 1

    Buprenorphine can reduce opioid-related mortality by 50% but only 1 in 5 US residents with opioid use disorder receive it.

  • 2

    In 2023, 42% of privately insured US residents under 65 were enrolled in high-deductible health plans, which may affect healthcare access.

  • 3

    Switching to a high-deductible health plan may decrease buprenorphine dispensing and increase opioid-related adverse events.

  • 4

    The study analyzed data from 2010 to 2023 to evaluate the impact of switching to a high-deductible health plan on buprenorphine access.

  • 5

    Findings indicated no significant changes in buprenorphine dispensing or outpatient visits after switching to a high-deductible health plan.

Original Source(s)

High-Deductible Health Plan Enrollment and Buprenorphine Dispensing

  • by Kao-Ping Chua, Amy S. Bohnert, Rena M. Conti, Pooja Lagisetty, Ushapoorna Nuliyalu, Thuy D. Nguyen

  • May 28, 2026

Related Content

Psychological adjustment and growth of graduate nursing students under the dual stress of research and practicum: a qualitative study

Beyond empirically supported treatments: a new contextualized evidence framework for evidence based psychology

Tuina combined with other therapies for treating insomnia: a systematic review and network meta-analysis